Erste Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,120
| Closed | -$54.8K | – | 758 |
|
|
2024
Q3 | $54.8K | Hold |
3,120
| – | – | ﹤0.01% | 510 |
|
|
2024
Q2 | $53.4K | Hold |
3,120
| – | – | ﹤0.01% | 508 |
|
|
2024
Q1 | $41.4K | Hold |
3,120
| – | – | ﹤0.01% | 507 |
|
|
2023
Q4 | $25.8K | Hold |
3,120
| – | – | ﹤0.01% | 527 |
|
|
2023
Q3 | $28.5K | Hold |
3,120
| – | – | ﹤0.01% | 526 |
|
|
2023
Q2 | $27K | Hold |
3,120
| – | – | ﹤0.01% | 553 |
|
|
2023
Q1 | $29.8K | Hold |
3,120
| – | – | ﹤0.01% | 566 |
|
|
2022
Q4 | $103K | Hold |
3,120
| – | – | ﹤0.01% | 531 |
|
|
2022
Q3 | $142K | Hold |
3,120
| – | – | ﹤0.01% | 512 |
|
|
2022
Q2 | $185K | Hold |
3,120
| – | – | ﹤0.01% | 514 |
|
|
2022
Q1 | $261K | Hold |
3,120
| – | – | 0.01% | 493 |
|
|
2021
Q4 | $665K | Hold |
3,120
| – | – | 0.01% | 401 |
|
|
2021
Q3 | $839K | Hold |
3,120
| – | – | 0.02% | 352 |
|
|
2021
Q2 | $815K | Hold |
3,120
| – | – | 0.02% | 363 |
|
|
2021
Q1 | $913K | Hold |
3,120
| – | – | 0.02% | 337 |
|
|
2020
Q4 | $854K | Sell |
3,120
-733
| -19% | -$201K | 0.02% | 349 |
|
|
2020
Q3 | $976K | Hold |
3,853
| – | – | 0.03% | 303 |
|
|
2020
Q2 | $1.3M | Hold |
3,853
| – | – | 0.05% | 274 |
|
|
2020
Q1 | $1.04M | Buy |
3,853
+1,000
| +35% | +$271K | 0.06% | 249 |
|
|
2019
Q4 | $923K | Sell |
2,853
-314
| -10% | -$102K | 0.04% | 284 |
|
|
2019
Q3 | $850K | Sell |
3,167
-5,866
| -65% | -$1.57M | 0.05% | 277 |
|
|
2019
Q2 | $4.7M | Buy |
9,033
+1,313
| +17% | +$683K | 0.25% | 107 |
|
|
2019
Q1 | $3.79M | Hold |
7,720
| – | – | 0.21% | 116 |
|
|
2018
Q4 | $3.84M | Buy |
+7,720
| New | +$3.84M | 0.26% | 104 |
|